Relapsed and refractory primary CNS lymphoma: treatment approaches in routine practice

Despite recent therapeutic progress and improved survival for many patients with primary central nervous system lymphoma (PCNSL), up to 50% of patients will experience refractory or relapsed disease following first-line treatment with high dose methotrexate (HD-MTX) based regimens. The majority of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambady, Prakash, Doolittle, Nancy D., Fox, Christopher P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612457/
https://www.ncbi.nlm.nih.gov/pubmed/35253010
http://dx.doi.org/10.21037/aol-21-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612457/
https://www.ncbi.nlm.nih.gov/pubmed/35253010
http://dx.doi.org/10.21037/aol-21-20

Ejemplares similares